Invesco Ltd. (IVZ)
IVZ (NYSE:Financial Services)
$33.56
+0.02
+0.06%
Today's Range: 33.13 - 33.64 |
IVZ Avg Daily Volume: 4,019,300
| Last Update: 05/24/13 - 4:03 PM EDT |
| Volume: 2,455,371 |
| YTD Performance: 28.56%
|
| Open: $33.31 |
| Previous Close: $33.54 |
| 52 Week Range: $20.49 -
$35.02 |
| Oustanding Shares: 444,646,972 |
| Market Cap: 15,135,782,927 |
6-Month Chart
TheStreet Ratings Grade for IVZ
| Buy |
Hold
|
Sell
|
| A+ |
A |
A- |
B+ |
B |
B- |
C+ |
C |
C- |
D+ |
D |
D- |
E+ |
E |
E- |
F |
Analysts Ratings
| Historical Rec |
Current |
1 Mo. Ago |
2 Mo. Ago |
3 Mo. Ago |
| Strong Buy |
10 |
8 |
9 |
9 |
| Moderate Buy |
3 |
3 |
3 |
3 |
| Hold |
5 |
7 |
7 |
6 |
| Moderate Sell |
0 |
0 |
0 |
0 |
| Strong Sell |
0 |
0 |
0 |
0 |
| Mean Rec. |
1.72 |
1.94 |
1.89 |
1.83 |
| Latest Dividend: |
0.23 |
| Latest Dividend Yield: |
2.64% |
| Dividend Ex-Date: |
05/15/13 |
| Price Earnings Ratio: |
21.96 |
|
| Price Earnings Comparisons: |
| IVZ |
Sector Avg. |
S&P 500 |
| 21.96 |
21.80 |
17.70 |
| Price Performance History (%Change): |
| 3 Mo |
1 Yr |
3 Y |
|
26.14%
|
55.06%
|
74.96%
|
|
| GROWTH |
12 Mo |
3 Yr |
CAGR |
| Revenue |
2.10 |
0.59 |
0.17 |
| Net Income |
-19.50 |
0.82 |
0.22 |
| EPS |
-5.10 |
0.94 |
0.24 |
| Earnings for IVZ: |
| EBITDA |
0.87B |
| Revenue |
4.18B |
|
Average Earnings Estimates
;Qtr (09/13);FY (12/13);FY (12/14)&HEADING_LIST1=Qtr (06/12);Qtr (09/12);FY (12/12);FY (12/13)) |
|
| Average Estimate |
$0.52 |
$0.54 |
$2.14 |
$2.49 |
| Number of Analysts |
14 |
13 |
16 |
16 |
| High Estimate |
$0.54 |
$0.56 |
$2.21 |
$2.59 |
| Low Estimate |
$0.46 |
$0.50 |
$1.91 |
$2.35 |
| Prior Year |
$0.41 |
$0.42 |
$1.91 |
$2.14 |
| Growth Rate (Year over Year) |
26.13% |
28.75% |
12.27% |
16.12% |
May 13, 2013 | 8:02 AM EDT
Shares of IVZ were downgraded to Neutral from Buy, said UBS. Progress toward margin target has been solid and is priced in. Price targe...
May 01, 2013 | 8:00 AM EDT
IVZ earnings estimates were increased as stronger cost controls are expected to lead to margin expansion, said Citigroup. Price target ...
Mar 01, 2013 | 8:23 AM EST
IVZ was added to Top Picks Live! at Citigroup. $34 price target. Deep YTD underpeformance.
Feb 05, 2013 | 8:14 AM EST
IVZ was downgraded from Outperform to Market Perform, BMO Capital said. Valuation call, based on a $29 price target.
Feb 01, 2013 | 6:39 AM EST
IVZ was downgraded from Overweight to Equal-weight, Morgan Stanley said. $30 price target. Company lacks near-term catalysts.
Nov 13, 2012 | 8:05 AM EST
Shares of IVZ now seen reaching $27.50, Citigroup said. Estimates also lowered as October AUM in line, but equities remain sluggish.&nb...
Sep 13, 2012 | 7:43 AM EDT
Shares of IVZ now seen reaching $28, according to BMO Capital. Estimates also increased, as the company is gaining market share.
Jun 12, 2012 | 7:31 AM EDT
IVZ estimates were cut through 2013, BMO Capital said. Company is hurt by lower market performance and currency headwinds. Outperform r...
Mar 08, 2012 | 8:25 AM EST
Shares of IVZ now seen reaching $30, according to Citigroup. Estimates also increased as model efficacy climbs and risks dissipat...
Jan 27, 2012 | 7:34 AM EST
Shares of IVZ now seen reaching $26, according to Credit Suisse. Estimates also upped, as the company is carrying a lot of earnings mom...
